Large clinical trial finds pirfenidone may help lung function in IPF patients
Sunday, May 17, 2009 - 12:42
in Health & Medicine
ATS 2009, SAN DIEGO?A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF. In a Phase III clinical study program called "CAPACITY," investigators discovered that the oral anti-fibrotic and anti-inflammatory agent, pirfenidone, could slow the d